07:58 AM EDT, 05/08/2024 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) reported Q1 non-GAAP earnings Wednesday of $0.48 per diluted share, up from $0.40 a year earlier.

Analysts polled by Capital IQ expected $0.51.

Revenue for the quarter ended March 31 was $3.82 billion, up from $3.66 billion a year earlier.

Analysts surveyed by Capital IQ projected $3.74 billion.

The drugmaker said it continues to expect full-year 2024 non-GAAP earnings of $2.20 to $2.50 per diluted share on revenue of $15.7 billion to $16.3 billion. Analysts polled by Capital IQ expect normalized EPS of $2.36 on revenue of $15.86 billion.

Shares of Teva Pharmaceutical Industries ( TEVA ) were 3.4% higher in recent Wednesday premarket activity.

Price: 14.42, Change: +0.47, Percent Change: +3.37